CHTR vs LAB · P/E 11, rev $55.09B vs rev $174.4M
Charter Communications Inc (CHTR) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CHTR and LAB stock pages for the full models.
Not investment advice.